Accessibility Menu
 
uniQure logo

uniQure

(NASDAQ) QURE

Current Price$15.34
Market Cap$947.47M
Since IPO (2014)+5%
5 Year-54%
1 Year+79%
1 Month-12%

uniQure Financials at a Glance

Market Cap

$947.47M

Revenue (TTM)

$16.10M

Net Income (TTM)

$198.97M

EPS (TTM)

$-3.48

P/E Ratio

-4.42

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Price

$15.34

Volume

195,719

Open

$16.43

Previous Close

$15.34

Daily Range

$13.22 - $16.43

52-Week Range

$8.66 - $71.50

QURE: Motley Fool Moneyball Superscore

53

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About uniQure

Industry

Biotechnology

Employees

221

CEO

Matt Kapusta, MBA, CPA

Headquarters

Amsterdam, 1105 BP, NL

QURE Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

-12%

Net Income Margin

-12%

Return on Equity

-207%

Return on Capital

-24%

Return on Assets

-24%

Earnings Yield

-22.62%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$947.47M

Shares Outstanding

61.60M

Volume

195.72K

Short Interest

0.00%

Avg. Volume

3.27M

Financials (TTM)

Gross Profit

$347.00K

Operating Income

$185.47M

EBITDA

$178.58M

Operating Cash Flow

$177.96M

Capital Expenditure

$439.00K

Free Cash Flow

$177.96M

Cash & ST Invst.

$622.54M

Total Debt

$536.59M

uniQure Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$5.57M

+6.6%

Gross Profit

$2.16M

-53.0%

Gross Margin

38.85%

N/A

Market Cap

$947.47M

N/A

Market Cap/Employee

$4.53M

N/A

Employees

209

N/A

Net Income

$37.09M

+49.4%

EBITDA

$49.19M

+7.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$85.95M

-71.5%

Accounts Receivable

$12.94M

+120.0%

Inventory

$0.00

N/A

Long Term Debt

$532.73M

+752.9%

Short Term Debt

$3.86M

+7.2%

Return on Assets

-24.12%

N/A

Return on Invested Capital

-24.46%

N/A

Free Cash Flow

$77.25M

-46.0%

Operating Cash Flow

$77.57M

-46.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ABCLAbCellera Biologics Inc.
$3.54+2.91%
VRDNViridian Therapeutics, Inc.
$14.95-2.80%
NUVBNuvation Bio Inc.
$4.60-0.65%
GLPGGalapagos N.V.
$28.40-0.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
INTCIntel
$62.38+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%

Questions About QURE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.